Clinical trial
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase
NCT07818876 is registered in ClinicalTrials.gov with University of Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase
- Lead sponsor
- University of Denver
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 21, 2026
- Completion date
- August 31, 2028
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.